Semler Scientific (NASDAQ:SMLR – Get Free Report) and Movano (NASDAQ:MOVE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.
Institutional & Insider Ownership
49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 16.6% of Movano shares are owned by institutional investors. 13.0% of Semler Scientific shares are owned by insiders. Comparatively, 13.4% of Movano shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Semler Scientific and Movano”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Semler Scientific | $68.18 million | 2.39 | $20.58 million | $2.79 | 8.36 |
| Movano | $852,000.00 | 45.41 | -$29.28 million | ($0.56) | -0.70 |
Analyst Ratings
This is a summary of recent ratings for Semler Scientific and Movano, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Semler Scientific | 0 | 0 | 0 | 1 | 4.00 |
| Movano | 0 | 0 | 1 | 0 | 3.00 |
Movano has a consensus price target of $2.00, indicating a potential upside of 408.00%. Given Movano’s higher possible upside, analysts plainly believe Movano is more favorable than Semler Scientific.
Profitability
This table compares Semler Scientific and Movano’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Semler Scientific | 25.62% | 21.17% | 19.40% |
| Movano | N/A | -452.96% | -233.43% |
Volatility & Risk
Semler Scientific has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.09, suggesting that its stock price is 91% less volatile than the S&P 500.
Summary
Semler Scientific beats Movano on 11 of the 15 factors compared between the two stocks.
About Semler Scientific
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
About Movano
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
